Chemical Structure : PLK1 inhibitor B4
货号: PC-24600Not For Human Use, Lab Use Only.
PLK1 inhibitor B4 is a novel small molecule inhibitor of polo-like kinase 1 (PLK1) with SPR KD of 5.6 uM, IC50 of 13.52 uM.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PLK1 inhibitor B4 is a novel small molecule inhibitor of polo-like kinase 1 (PLK1) with SPR KD of 5.6 uM, IC50 of 13.52 uM.
B4 inhibits PLK1 phosphorylation as well as decreases the abundance of PLK1 in A549/DDP and A549 cells.
B4 exhibits a potent cytotoxic activity in A549 cells with an IC50 value of 6.8 μM.
B4 specifically binds to PLK1 PBD and inhibits its activity in A549/DDP cells
B4 enhances cisplatin sensitivity in vitro and in vivo by blocking PLK1/PRC1 signaling
B4 (30 mg/kg) exhibits in vivo anticancer activity in an A549/DDP xenograft mice model, combination with cisplatin elicites dramatic regression of drug-resistant tumors.
分子量 | 505.51 | |
分子式 | C24H22F3N3O4S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Li P, et al. Cell Death Dis. 2025 May 12;16(1):374.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright